These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 8609166)

  • 1. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
    French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J
    J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnover.
    French LE; Tschopp J
    Behring Inst Mitt; 1996 Oct; (97):156-60. PubMed ID: 8950473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas system is a key regulator of germ cell apoptosis in the testis.
    Lee J; Richburg JH; Younkin SC; Boekelheide K
    Endocrinology; 1997 May; 138(5):2081-8. PubMed ID: 9112408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas ligand expression is restricted to nonlymphoid thymic components in situ.
    French LE; Wilson A; Hahne M; Viard I; Tschopp J; MacDonald HR
    J Immunol; 1997 Sep; 159(5):2196-202. PubMed ID: 9278307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover.
    Bennett MW; O'Connell J; O'Sullivan GC; Roche D; Brady C; Collins JK; Shanahan F
    Dis Esophagus; 1999; 12(2):90-8. PubMed ID: 10466040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.
    Xerri L; Devilard E; Hassoun J; Mawas C; Birg F
    Mol Pathol; 1997 Apr; 50(2):87-91. PubMed ID: 9231156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of dexamethasone on apoptosis and expression of Fas/FasL system in lung tissues of ALI rats].
    Song Y; Mao B; Qian G
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):23-6. PubMed ID: 11778176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene.
    Ayroldi E; D'Adamio F; Zollo O; Agostini M; Moraca R; Cannarile L; Migliorati G; Delfino DV; Riccardi C
    Blood; 1999 Nov; 94(10):3456-67. PubMed ID: 10552956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas and Fas-ligand expression in human pancreatic cancer.
    Kornmann M; Ishiwata T; Kleeff J; Beger HG; Korc M
    Ann Surg; 2000 Mar; 231(3):368-79. PubMed ID: 10714630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
    von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
    Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.
    Pinkoski MJ; Droin NM; Lin T; Genestier L; Ferguson TA; Green DR
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16174-9. PubMed ID: 12454289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas/FasL-mediated apoptosis in perinatal murine lungs.
    De Paepe ME; Mao Q; Embree-Ku M; Rubin LP; Luks FI
    Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L730-42. PubMed ID: 15355863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells.
    De Paepe ME; Mao Q; Chao Y; Powell JL; Rubin LP; Sharma S
    Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L647-59. PubMed ID: 16148053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas ligand-induced apoptosis as a mechanism of immune privilege.
    Griffith TS; Brunner T; Fletcher SM; Green DR; Ferguson TA
    Science; 1995 Nov; 270(5239):1189-92. PubMed ID: 7502042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat corpus luteum during apoptosis-mediated luteolysis.
    Roughton SA; Lareu RR; Bittles AH; Dharmarajan AM
    Biol Reprod; 1999 Apr; 60(4):797-804. PubMed ID: 10084951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand expression coincides with alveolar cell apoptosis in late-gestation fetal lung development.
    De Paepe ME; Rubin LP; Jude C; Lesieur-Brooks AM; Mills DR; Luks FI
    Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L967-76. PubMed ID: 11053034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege.
    O'Connell J; Bennett MW; O'Sullivan GC; O'Callaghan J; Collins JK; Shanahan F
    Clin Diagn Lab Immunol; 1999 Jul; 6(4):457-63. PubMed ID: 10391843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids.
    Yang Y; Merćep M; Ware CF; Ashwell JD
    J Exp Med; 1995 May; 181(5):1673-82. PubMed ID: 7536793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.